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Abstract
Neuronal high-voltage-activated (HVA) Ca
2+ channels are rapidly inactivated by a mechanism that is termed Ca
2+-
dependent inactivation (CDI). In this study we have shown that b-adrenergic receptor (bAR) stimulation inhibits CDI in rat
thalamocortical (TC) relay neurons. This effect can be blocked by inhibition of cAMP-dependent protein kinase (PKA) with a
cell-permeable inhibitor (myristoylated protein kinase inhibitor-(14–22)-amide) or A-kinase anchor protein (AKAP) St-Ht31
inhibitory peptide, suggesting a critical role of these molecules downstream of the receptor. Moreover, inhibition of protein
phosphatases (PP) with okadaic acid revealed the involvement of phosphorylation events in modulation of CDI after bAR
stimulation. Double fluorescence immunocytochemistry and pull down experiments further support the idea that
modulation of CDI in TC neurons via bAR stimulation requires a protein complex consisting of CaV1.2, PKA and proteins from
the AKAP family. All together our data suggest that AKAPs mediate targeting of PKA to L-type Ca
2+ channels allowing their
phosphorylation and thereby modulation of CDI.
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Introduction
Voltage-gated Ca
2+ channels of the plasma membrane consist
three subfamilies (CaV1, CaV2 and CaV3) [1]. They are composed
of 10 pore-forming a1 channel subunits and are important
components of a universal cellular Ca
2+ signaling tool kit [2].
Voltage-dependent Ca
2+ channels are one of the main routes of
cellular Ca
2+ entry. Intracellular Ca
2+ ions control processes as
diverse as cell proliferation, neuronal development and transmitter
release [2]. All of these functions have to be accomplished within a
narrow range of Ca
2+ concentrations. CDI of voltage-dependent
Ca
2+ channels is an auto-inhibitory feedback mechanism control-
ling Ca
2+-influx [3,4]. Previously we have shown that in TC
neurons of the dorsal part of the lateral geniculate nucleus (dLGN),
Ca
2+-induced Ca
2+ release (CICR) contributes to intracellular
Ca
2+ transients [5], leads to the activation of Ca
2+-dependent K
+
channels and thereby supports regular tonic firing [6]. Further-
more, CDI, which is under the control of multiple biochemical
and activity-dependent mechanisms, has been shown to limit Ca
2+
entry into TC neurons [7,8,9,10]. Stimulation of the bAR/
adenylyl cyclase (AC)/PKA-dependent pathway in TC neurons
mediates behavioural state-dependent shifts in thalamic activity
modes by modulating pacemaker channels, L-type Ca
2+ channels,
and Ca
2+-dependent K
+ channels [3,11]. Direct application of
cAMP and the catalytic subunit of PKA reduced the degree of
CDI in TC neurons [9]. Although cAMP-dependent signaling and
CDI represent prominent mechanisms in TC neuron function,
their possible functional coupling by direct stimulation of bAR has
not been investigated in these neurons yet. Recent studies in
cardiac [12] as well as in hippocampal cells have shown a
functional link between bAR and one type of L-type Ca
2+
channels, namely CaV1.2, via PKA [13,14], however a possible
link to CDI has not been addressed. Furthermore, AKAP has been
shown to be an important element in organizing bAR-dependent
pathways in neurons [13,15,16].
Although dephosphorylation of Ca
2+ channels by calcineurin
(PP2B) has originally been proposed to be the crucial mechanism
of CDI [17], calmodulin closely tethered to the channel has been
identified as the Ca
2+ sensor and central mediator of this process
[18,19,20]. The role of phosphorylation/dephosphorylation in
CDI attracted less attention, although the close association of
CaV1.2 channels, phosphorylating PKA, and dephosphorylating
calcineurin has been shown [17]. Based on the finding that b2ARs
are directly associated with one of their main effector channels,
namely CaV1.2, via a protein complex also containing G-proteins,
AC, PKA, and a counterbalancing protein phosphatase [13], it
was also suggested that this protein complex might be the basis for
b-adrenergic modulation of CDI [3] (Figure S1). Here we provide
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e27474evidence for this hypothesis and show that stimulation of bARs
reduces CDI in TC neurons via a protein complex including
AKAP and PKA.
Materials and Methods
Ethics Statement
All experiments were carried out in accordance with the
European Committees Council Directive (86/609/EEC) and
approved by the local animal care committee (Landesverwaltung-
samt Sachen-Anhalt, AZ: 42502/5.19 UNI MD).
Reverse transcription-polymerase chain reaction (RT-PCR)
assays
PolyA
+mRNA was prepared from freshly dissected thalamic tissue
(the ventrobasal thalamic complex (VB) and dLGN were visually
identified) or whole brain by extraction with Trizol reagent according
to the manufacturer’s instruction (Oligotex Direct mRNA, Qiagen,
Hilden, Germany). First-strand cDNA synthesis was primed with
oligo (dT) from 0.5–1 mg of mRNA, using the SuperScript II enzyme
(Invitrogen Life Technologies). Specific primers for calcium channels
a1C-a1E, G-proteins, adenylatecyclase, and b-receptors were used
according to manufacturer description (Figure 1A–1F). Accession
numbers for used primers were: Alpha1S (nucleotides 445–828)
No. L04684; Alpha1C (nucleotides 2624–3033) No. NM012517;
Alpha1D (nucleotides 3691–4200) No. NM017298; Alpha1F (nucle-
otides 3196–3608) No. NM0053701; Alpha1A (nucleotides 5115–
5387) No. NM012918; Alpha1B (nucleotides 1742–2051)
No. NM147141; Alpha1E (nucleotides 5831–6377) No. NM019294;
Galpha q (nucleotides 188–560) No. AF234260; Galpha11 (nucleo-
tides 139–554) No. AF239674; Galpha i–1 (nucleotides 669–1198)
No. NM013145; Galpha i-2 (nucleotides 1125–1520) No. 031035;
Galpha i-3 (nucleotides 1993–2367) No. NM013106; b1–AR
(nucleotides 742–1104) No. NM012701; b2-AR (nucleotides 676–
964) No. NM012492; b3-AR (nucleotides 398–797) No. NM013108;
AC1 (nucleotides 1361–1863) No. XM223616; AC6 (nucleotides
1581–1940) No. NM012812; AC8 (nucleotides 3001–3480)
No. NM017142; AKAP5 (nucleotides 122–589 No. NM 133515;
AKAP7 (nucleotides 494–1059) No. NM 001001801; Gs (nucleotides
332–756) No. NM 019132.
Cell type-specific RT - PCR
Brain tissue from P14–P24 Long Evans rats consisting of
dLGN was sliced using a vibratome to 500 mM. After try-
psinization of tissue blocks cells were visually identified under the
microscope. Complete cells were sucked into the pipette and
transferred into 3 ml carrier RNA buffer (RNeasy Micro Kit,
QIAGEN) by breaking the tip of the pipette and expelling 3 ml
of solution with positive pressure. The pipette solution (6 ml)
was supplemented with a recombinant ribonuclease inhibitor
(0.24 U/ml; RNasin; Promega, Madison, WI, USA). Cytoplasm
from single, identified cells were pooled (interneurons and TC
neurons, respectively), RNA was isolated without DNase treat-
ment using an RNA isolation kit (RNeasy Micro Kit, QIAGEN),
and reverse transcription (RT) protocol was used for cDNA
according to manufactures protocol. Integrity of all obtained
cDNAs was confirmed by using primers for the housekeeping
gene GAPDH. After confirmation of integrity, cDNAs were used
for standard RT-PCRs with specific primers for each gene of
interest (AKAP 5; AKAP 7; AC stimulatory G-protein, Gs;
Figure 2A). PCR products were separated by size on 1% agarose
gels and visualised using an Eagle eye system after ethidium
bromide staining.
Quantitative Real – time PCR
Real-time PCR was performed using the Real PCR Master Mix
2.5X (Eppendorf) and the ABI Prism 7000 Sequence Detection
System (Applied Biosystems); PCR program was: 2 min at 50uC,
10 min at 95uC, 50 cycles: 15 s at 95uC and 1 min at 60uC.
Analysed probes were AKAP 5, AKAP 7, and b-2 microglobulin
as the internal reference gene used for normalisation (Figure 2B).
All primers were purchased from Applied Biosystems. Results were
analysed with the ABI Prism 7000 SDS software. The efficiency of
real-time primer/probes was nearly identical. Quantification was
done using the comparative Ct method as described earlier [21].
In a standard PCR GAPDH (nucleotides 789–1028, accession
No. NM017008) expression was checked as a positive control to
confirm the integrity of transcribed cDNA. The PCR protocol for
GAPDH amplification was: 3 min 94uC; 50 cycles (30 s 94uC,
1 min 61uC, 1 min 72uC); 7 min 72uC.
Tissue Preparation
Thalamic slices were prepared from juvenile postnatal day (P)
12–P24 Long–Evans rats. After anaesthesia with isoflurane,
animals were decapitated and a block of tissue containing the
dLGN was rapidly removed and placed in chilled (2–4uC),
oxygenated slicing solution (pH 7.35, with NaOH) containing the
following (in mM): sucrose, 195; glucose, 11; Pipes, 20; KCl, 2.5;
MgSO4, 10; and CaCl2, 0.5. Coronal slices of the thalamus were
cut at 300 mm on a vibratome and kept submerged in artificial
cerebrospinal fluid (ACSF; pH 7.35, with 95% O2-5% CO2)
containing the following (in mM): NaCl, 125; KCl, 2.5;
NaH2PO4, 1.25; NaHCO3, 22–26; MgSO4, 2; CaCl2, 2; and
glucose, 10. Slices were kept for 20 min at 34uC before being
cooled to room temperature, and allowed to rest for 60 to
90 min.
Patch clamp recordings
Whole-cell recordings under voltage clamp condition were
performed on visually identified TC neurons of the dLGN at
room temperature (21–23uC) using borosilicate glass pipettes
(GC150TF-10, Clark Electromedical Instruments, Pangbourne,
UK) connected to an EPC-9/2 amplifier (HEKA Electronics,
Lamprecht, Germany). Typical electrode resistances amounted to
2–4 MV, while access resistance was 5–15 MV. Series resistance
compensation was routinely used (30%). Voltage-clamp experiments
were governed by Pulse software (HEKA, Germany). For standard
recordings the following solutions were used: (i) extracellular solution
(in mM): NaCl, 125; KCl, 2.5; NaH2PO4, 1.25; NaHCO3, 22–26;
MgSO4,2 ;C a C l 2, 2; and glucose, 10; TTX, 0.001; 4-AP, 4; pH 7.35
with NaOH. (ii) Intracellular solution: Cs-gluconate, 85; Cs3-citrate,
10; NaCl, 10; KCl, 1; EGTA. 1.1; CaCl2,0 . 1 ;M g C l 2,0 . 2 5 ;H E P E S ,
10; TEA-Cl,15; Mg-ATP, 3; Na2-GTP,0.5; pH 7.25 with CsOH.In
some experiments equimolar concentrations of ascorbic acid were
added to the bath solution in order to prevent oxidation of the drugs.
HVA Ca
2+ currents were evoked from a holding potential of
240 mV by a double-pulse protocol in which conditioning pulses
to varying potentials (240 to +60 mV, 200 ms duration) were
followed by a brief gap (240 mV, 50 ms) and a subsequent
analyzing test pulse to a fixed potential of +10 mV (200 ms)
(Figure 3A). For standard recordings Ca
2+ was used as a charge
carrier and 1.1 mM EGTA was included to the intracellular
solution. The degree of inactivation (Dinact) was determined by
dividing the current amplitudes elicited by a test pulse to +10 mV
with maximal and minimal preceding conditioning current
amplitude (Figure 3B–3C, Dinact=[12(A2/A1)]6100(%)). A2
(Imin, Figure 3C) represents the minimal current amplitude after
a preceding conditioning pulse, as measured at the beginning of
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A1 (Imax, Figure 3C) representing the maximal current amplitude
(lower arrowhead, Figure 3B), as measured without a preceding
conditioning pulse. GraphPad Prism 5.0 and Microcal Origin 6.0
software were used for data analysis and figure plotting.
Drugs
The following drugs were used: isoproterenol hydrochloride,
propranolol hydrochloride, xamoterol hemifumarate, salmeterol,
BRL 37344, sodium salt, CGP 20712 dihydrochloride, ICI 118,551
hydrochloride,SR 59230Ahydrochloride,okadaicacid,PKA inhibitor
myristoylated PKI 14–22 amide (all from Tocris, USA). Equimolar
concentrations of ascorbic acid were added to the extracellular bath
solution in order to prevent oxidation of the drugs.The selective AKAP
inhibitor InCELLect
TM AKAP St-Ht31 and the corresponding control
peptide were purchased from Promega (Germany).
Cell culture
After incubation for 5 minutes at room temperature with 2 ml
Trypsin solution, immortalized kidney cells of the African green
monkey (COS-7 cells) were collected with 10 ml cell culture medium
and transferred into a 15 ml Falcon tube. Cell pellets obtained after
centrifugation at 500 x g for 5 minutes at 4uC were resuspended in
10 ml of Dulbecco’s modified Eagle medium (DMEM; Gibco,
Eggestain, Germany). Transfection was done according to the
manufacturer’s instructions (Invitrogen, Germany). DNA-Lipofecta-
mine complexes were added into the flask and cells were left in
incubator for the next two days. 24 hours after transfection sodium-
butyrate was added in order to enhance expression of transfected
proteins.48 hours after transfection, the cellswerelysed and obtained
lysates were either used immediately or stored at 220uC. For GFP
constructs, transfection efficiency was analyzed under a fluorescence
microscope (Zeiss axioplan microscope, Carl Zeiss, Jena, Germany).
Figure 1. Tissue-specific expression patterns of mRNAs of the main components of bAR signaling in the dLGN of Long Evans rats.
RT-PCRs of mRNA from whole brain extracts (A) and VB (B) show that the a1C subunit (colored squares) as well as other Ca
2+ channels forms are
widely expressed. The skeletal muscle form a1S was not found in both regions (as well as in dLGN, see Figure F). In all experiments, appropriate
markers for size were used in order to assure detection of specific forms of Ca
2+ channels. (C) Using specific primers for all three types of bAR, we
have shown specific expression of only b1 and b2AR. b3AR was neither expressed in VB nor in dLGN. (D) Following the same procedure, we have
shown the expression of some of the G proteins coupled with metabotropic receptors (Ga and Gi) in dLGN. In all experiments specific markers for size
were used. (E) Expression of three different adenylate cyclases, namely type 1, 6 and 8 with two isoforms A/B and C in dLGN.
doi:10.1371/journal.pone.0027474.g001
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from the dorsal thalamus and hippocampus
Dorsal thalami were prepared from embryos (Long-Evans rats)
at stage E19 and subsequently transferred into ice-cold HBSS
without Ca
2+/Mg
2+. After triple washing with HBSS (5 ml),
2.0 ml HBSS containing 0.5% trypsin was added to the tissue,
followed by incubation at 37uC for 20 min. Thereafter tissue was
washed again five times with 5 ml HBSS and finally transferred
into tubes (2 ml) with HBSS containing 0.01% DNaseI. For
dissociation thalamic tissue was pressed slowly three times through
a 0.9 mm gauge needle followed by three passages through a
0.45 mm gauge needle. The remaining cell suspension was poured
through a nylon tissue into a 50 ml tube and filled up with 18 ml
DMEM. After estimating cell quantity, the suspension was diluted
with DMEM in order to achieve a cell density of 30,000 cells/ml.
A 500 ml aliquot of this suspension was placed on each well of a
Figure 2. Single cell and qRT-PCR expression profiles of AKAP5, AKAP7 and the Gs subunit of G proteins. (A) Two different cell types
are expressed in LGN, interneurons that are GAD67 positive and TC neurons that are GAD67 negative. These types of cells were collected under visual
control and classified based on their morphological differences. Thereafter, mRNA was extracted. Representative PCR gel photo showing bands
specific for AKAP5, AKAP7, and the Gs subunit of G proteins. Note that AKAP5 is only expressed in TC neurons while AKAP7 was not detectable. (B)
mRNAs were isolated from the indicated brain tissues. qRT-PCR analysis showed expression of both AKAP5 and AKAP7 genes in the dLGN.
doi:10.1371/journal.pone.0027474.g002
Figure 3. Identification of CDI in TC neurons. (A) Scheme of the double-pulse protocol used to elicit HVA Ca
2+ currents. TC neurons were held
at 240 mV and conditioning pulses to varying potentials (240 to +60 mV, 200 ms duration) were followed by a brief gap (240 mV, 50 ms) and a
subsequent analyzing test pulse to a fixed potential of +10 mV (200 ms). (B) Family of representative current traces elicited by the pulse protocol
shown in (A). (C)D inact equation for calculating effects of CDI in TC neurons.
doi:10.1371/journal.pone.0027474.g003
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coated coverslips. The cell cultures were incubated at 37uC and
5% CO2 up to the appropriate time points. Between 3
rd and 4
th
day of incubation, AraC (final concentration: 6 mM) was added to
prevent further growth of glial cells.
Primary hippocampal cells were prepared in the same way as
described for thalamic neurons and grown in culture until day 10
to 14. Some of the cover slips were taken out and immediately
fixed with 4% paraformaldehyde (PFA), stained with PKARIIb
antibody (1:500, BD Bioscience; see below) and used as control.
For comparison cells were treated with bAR agonist isoproterenol
hydrochloride (50 mM) for 5 minutes before fixation and
PKARIIb antibody staining. All cells were then incubated with
the appropriate secondary antibody, mounted on microscope
slides, and analysed under the microscope. Finally, distances (in
pixels) between the dendritic localizations of PKA and the centre
of the soma were quantified using MetaMorph software (Visitron
Systems GmbH, Puchheim, Germany).
Immunocytochemistry
After 10–14 days in vitro (DIV 10–14), PFA-fixed thalamic cells
were washed two times with 25 mM glycine in phosphate buffered
saline (PBS, 10 mM), one time with PBS, and subsequently
preincubated at room temperature in PBS-blocking solution
containing 10% horse normal serum, 2% bovine serum albumin,
5% sucrose, and 0.3% Triton X-100. After 1 h, the following
primary antibodies were added in different combinations to the
blocking solution and incubated for 90 min at room temperature:
rabbit anti-CaV1.2 (1:200, Alomone Labs, Israel); mouse anti-
cAMP-dependent protein kinase type II beta regulatory subunit
(PKARIIb, 1:500, BD Bioscience, USA); rabbit anti-b2-AR (H-73
1:400, Santa Cruz, USA); mouse anti-microtubule-associated
protein 2 (MAP2, HM-2, 1:1000, Sigma, Germany); goat anti-
AKAP-150 (N-19, Santa Cruz, USA); sheep anti-protein phos-
phatase 2A (PP2A, Acris, Germany). Cultures were then treated
with PBS including 0.3% Triton X-100, incubated with
appropriate specific fluorescent secondary antibodies: Alexa 488
donkey anti-sheep IgG; Alexa 488 goat anti-mouse IgG; Alexa 488
goat anti-rabbit IgG; Alexa 488 rabbit anti-goat IgG; Alexa 647
donkey anti-mouse IgG; Alexa 647 donkey anti-goat IgG; Alexa
647 donkey anti-rabbit IgG, (all from Molecular Probes,
Invitrogen, Germany); Cy3-conjugated goat anti-rabbit IgG;
Cy3-conjugated goat anti-mouse IgG; Cy3-conjugated rabbit
anti-goat IgG, (all from Dianova, Germany) for 90 min, washed,
and mounted with Mowiol. Omission of primary and secondary
antibodies resulted in lack of fluorescent signals.
Immunohistochemistry
Long–Evans rats P25–27 were deeply anesthetized using
pentobarbital (50 mg/kg body weight) and transcardially perfused
with PBS, followed by an ice-cold 4% PFA/PBS for 35–40 min.
Brains were removed, postfixed for 4 h in 4% PFA/PBS, and
cryoprotected with 30% sucrose. Coronal sections (20 mm) were
cut at the level of the dLGN, mounted onto polylysineslide glass
(Menzel, Germany), and air dried. For detection of CaV1.2, fresh-
frozen sections were used. In this case, brains from isoflurane-
anesthetized rats were removed and frozen in 250uC isopentane.
Cryostat coronal sections of 20 mm thickness were cut at the level
of the dLGN, thaw-mounted onto Polylysine slide glass, air dried,
and fixed in 4% PFA/PBS for 10 min. After permeabilization with
0.1% Triton X-100 in PBS for 10 min and several washeswith
PBS, sections were blocked with 10% normal horse serum (NHS),
2% BSA in PBS for 3 h to minimize nonspecific binding before
incubation of slices with primary antibodies (rabbit anti-CaV1.2,
1:200; mouse anti-PKARIIb, 1:500) in 2% NHS, 2% BSA in PBS
at 4uC for 16–18 h. After washing, sections were incubated withto
Cy3-conjugated donkey anti- rabbit IgG (1:400 in 2% NHS, 2%
BSA in PBS, Dianova, Germany) or Alexa488 goat anti-mouse
IgG (1:750 in 2% NHS, 2% BSA in PBS, Molecular probes,
Invitrogen, Germany) for 1.5 h, washed again, and mounted with
Immumount.
Culturing of COS-7 cells and pull down assays
Dulbecco’s modified Eagle medium (DMEM+; Gibco, Egges-
tain, Germany) and washing buffer PBS were warmed to 37uC
and frozen trypsin aliquots were thawed at room temperature.
COS-7 cells (grown to confluency) were washed once with PBS.
After incubation for 5 minutes at room temperature with trypsin
(2 ml), cells were collected with 10 ml cell culture medium and
transferred into a 15 ml Falcon tube. Cell pellets obtained after
centrifugation at 500 x g for 5 minutes at 4uC were resuspended in
10 ml of Dulbecco’s modified Eagle medium (DMEM; Gibco,
Eggestain, Germany). Transfection of the cells was done according
to the manufacturer’s instruction (Invitrogen, Germany). Trans-
fection was conducted for 2 days and after 24 hours sodium-
butyrate was added in order to enhance expression of transfected
proteins. In the following cells were lysed and lysates were used
immediately or stored at 220uC. For GFP constructs, transfection
efficiency was analyzed under a fluorescence microscope (Zeiss
Axioplan microscope, Carl Zeiss, Jena, Germany).
Transfected COS-7 cells expressing proteins of interest tagged
to GFP or c-myc were scraped in medium and transferred to a
15 ml Falcon tube. Cell flask was washed with 2 ml of Tris-
buffered saline (TBS) and the solution was pulled with scraped
cells. Content of the cells was made accessible by repeating two
times centrifugation (1000 x g, 5 min, 4uC), discarding the
supernatant, resuspension of cells in 1 ml of TBS, and transfer
to a 1.5 ml Eppendorf tube. In order to disrupt cells, the pellet was
frozen and thawed using liquid nitrogen. After careful resuspen-
sion in 200 ml of TBS/Triton X-100 and vortexing, the lysate was
rotated for 1 h at 4uC. A cleared lysate which was obtained after
20 min centrifugation (14000 rpm, at 4uC) was diluted with TBS
containing 0.2% Triton X-100 and either used directly for pull
down assay or stored at 220uC for further use.
Next, 50 ml matrix beads coupled to one of the proposed
binding partners with GST or MBP tag were washed 2x and
equilibrated in TBS containing 0.1% Triton X-100. Appropriate
lysates from COS-7 cells (200–300 ml) were added and beads were
gently shaken overnight at 4uC. On the next day matrixes were
centrifuged (5 min, 600 x g. 4uC) washed three times (TBS/0.2%
Triton X-100, 10 min) to remove unbound proteins. Bound
proteins were eluted by 5 min boiling with 4 x SDS sample buffer
and either loaded on SDS-PAGE gels directly or stored at 220uC
for further use.
Immunoprecipitation
AKAP5-GFP, co-expressed with PKARIIb-c-myc in COS-7
cells, was immunoprecipitated using mMACS
TM Epitope Tag
Protein Isolation Kit (Miltenyi Biotec, Germany) according to
manufacturer’s instructions. Eluted probes were loaded on SDS-
PAGE and presence of proteins interacting with AKAP5 was
detected after Western blot analysis using a PKARIIb specific
antibody (BD Bioscience, USA).
Western blotting procedures
For immuno-blot experiments solubilized protein fractions were
separated on 5–20% SDS-polyacrylamide gradient gels and
subsequently transferred to nitrocellulose membranes (90 min,
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glycine, 0.02% SDS and 20% methanol. After blotting, mem-
branes were blocked with 5% dry milk and 0.1% Tween 20 in
TBS for 2 h and subsequently incubated at 4uC overnight with a
specific dilution of antibodies in TBSA containing 0.1% Tween
20. After final washing steps, the blots were incubated with HRP-
conjugated secondary antibodies (1:5000) for 2 h, washed again
and finally developed using ECL films.
Microscopy
Immunofluorescence analysis of cultured neurons was done
using a computer-controlled inverted laser scanning microscope
(Leica, Bensheim, Germany) allowing recording of Z-stacks and
enabling 3D deconvolution of the obtained images. Image analysis
was done using MetaMorph, ImageJ (NIH), and Adobe Photoshop
CS (version 9.0 CS2) software.
Data analysis
Statistical data analysis was done by Student’s t test or one way
ANOVA as indicated using GraphPad Prism 5 and Microcal
Origin 6. All values were presented as mean 6 SEM. As we were
able to demonstrate a Gaussian distribution for the three main
parameters (current amplitude, Dinact and ratio of inactivation)
analyzed in the present study under control conditions, statistical
significance was evaluated by Student’s t-test. Where applicable,
control values were compared with corresponding values obtained
during drug application for the same cells. When intracellular
substance application had to be used, an appropriate number of
control cells was recorded from the same slice and used for
statistical comparison. Values of P,0.05 were considered
statistically significant.
Results
PCR expression patterns of the main components of the
bAR signaling cascade in dLGN
In a first attempt to investigate the modulation of CDI via
bARs, we analyzed the expression patterns of the main
components of the proposed b-AR signaling pathway in dLGN
TC neurons by performing RT-PCR analyses on a tissue and
single cell level. Expression of RNA of the main neuronal L-type
Ca
2+ channels (CaV1.2/a1C, CaV1.3/a1D) were found in whole
brain samples (Figure 1A), the VB (Figure 1B), and dLGN
(Figure 1F). The skeletal muscle type CaV1.1/a1S and the retina-
specific CaV1.4/a1F were not detected in thalamic tissue
(Figure 1), indicating a specific RT-PCR amplification. Further-
more, the specific expression of main components of the bAR
signaling cascade supposed to be involved in CDI modulation in
TC neurons was confirmed in dLGN tissue (Figure 1C–1E).
The expression of AKAP and the stimulatory G protein (Gs)
was probed in a cell type-specific manner using single identified
cells obtained from dLGN tissue. Acutely dissociated cells were
observed under an inverted microscope and small bipolar
interneurons and larger multipolar TC neurons were visually
identified by using established criteria [22,23]. Single cells were
collected by means of a suction pipette and used for standard PCR
or quantitative real-time PCR (qRT-PCR). Because of very low
amounts of the mRNA species targeted here, in some sets of
experiments it was necessary to pool up to 10 cells. As Figure 2A
shows, in three independent experiments (n=3) the Gs subunit
was expressed in both types of neurons, AKAP5 was only
expressed in TC neurons, and AKAP7 was not detected at the
single cell level. To obtain larger amounts of mRNA, we also
performed qRT-PCR with samples from dLGN tissue. Using
specific primers for AKAP5 and AKAP7, we were able to detect
expression signals for these two genes in dLGN with almost
identical expression levels (Figure 2B). Of note, that while AKAP7
is nearly equally expressed in the brain, AKAP5 exhibited a
slightly higher expression level in the primary somatosensory
cortex and hippocampus (data not shown). In view of positive
signals for both AKAP subtypes from dLGN tissue and AKAP5 in
single TC neurons, the absence of positive PCR bands for AKAP7
in extracts from single cells indicted that the amount of mRNA
was below the detection limit of the method used here or pointed
to an expression in other cell types present in intact tissue (glia
cells, endothelial cells, blood cells).
CDI is active in TC neurons in brain slices
Next, we demonstrated the occurrence of CDI in TC neurons in
brain slices. Total HVA Ca
2+ current, which is composed of about
40% current through L-type channels, was measured in the
presence of TTX (1 mM) [24]. We have shown before that
blocking of L-type calcium channels using nifedipine (1 mM),
(n=8) indeed significantly reduced CDI [5]. HVA Ca
2+ currents
were recorded in 160 cells and a double pulse voltage protocol
(Figure 3A) was used to effectively disclose CDI [3]. If CDI is
operative, the current evoked by the test pulse should exhibit a U-
shaped dependence on the conditioning pulse potential, with
maximal inactivation occurring at the peak of the conditioning
pulse current-voltage (I–V) relationship. Under standard condi-
tions the I–V relationship of the conditioning pulse demonstrated
HVA Ca
2+ currents with an activation threshold of –40 mV,
maximal inward current at around +10 mV, and an apparent
reversal potential at around +60 mV (data not shown). The test
pulse I–V (peak amplitude of the test pulse current plotted vs.
conditioning pulse voltage) revealed minimal current occurring at
+10 mV (Figure 3C) as expected for a CDI mechanism. With
respect to the amplitude of the test pulse current elicited from the
holding potential of –40 mV, the degree of inactivation (Dinact)
was 39.5 6 0.5% (n=100; Figure 3C). By default, the test pulse
I–V was obtained with the conditioning pulses altered in 10 mV
increments from 240 mV (Figure 3A). I–V relationships were
obtained as described before and all experiments were done using
a protocol resulting in maximal CDI [5]. Taken together, these
findings demonstrate a CDI mechanism in TC neurons in the slice
preparation that is very similar to that described in these cells after
acute isolation [9].
The role of b-AR in CDI modulation of L-type Ca
2+
channels
Since activation of the cAMP/PKA pathway is able to reduce
CDI in isolated TC neurons [9,10], activation of bARs is expected
to modulate CDI of L-type calcium channels in the dLGN. bARs
consist of three similar receptor subtypes (b1, b2, b3). Using
commercially available pharmacological substances, we specifical-
ly stimulated and blocked receptor subtypes and evaluated their
possible relevance for CDI modulation. First, we used general
agonists and antagonists for bARs, namely isoproterenol and
propranolol (data not shown). Experiments testing bAR activation
alone using 10 mM isoproterenol revealed an inhibiting influence
of bAR stimulation on CDI. Dinact was decreased to 35.762%
(n=4, p.0.05) as compared to control (Dinact=40.163%). The
effect of isoproterenol on CDI was reversed by co-application of
the bAR antagonist propranolol (100 mM, Dinact=43.762.1,
n=5; p.0.05; control Dinact=46.161.6%, n=5; data not
shown). These experiments demonstrate a general role of bAR
in modulation of CDI in TC neurons. The rather moderate effect
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processes in TC neurons [9] (see below).
Next, we tested agonists which bind preferentially to one of the
three bAR subtypes. Therefore xamoterol (b1AR agonist),
salmeterol (b2AR agonist), and BRL 37344, (b3AR agonist) were
used. Challenging TC neurons with xamoterol (10 mM), reduced
the degree of inactivation from 43.862.3% to 37.461.8% (n=4,
p,0.05). This decrease was similar to that induced by salmeterol
(10 mM) application (reduction of Dinact from 39.062.2% to
34.560.3%, n=4, p,0.05; data not shown) and BRL 37344
(10 mM) application (reduction of Dinact from 43.860.6% to
38.360.8%, n=4, p,0.05; data not shown). To minimize side
effects of each drug on non-preferred bAR subtypes and to further
enhance the specificity of our pharmacological approach, we used
agonists that prefers one type of receptor (in 10 mM concentration)
in combination with antagonists for the other two receptor types
(in 100 mM concentration), thereby allowing to more selectively
investigate the role of each type of receptor in CDI modulation.
The following antagonists were applied: CGP 20712 (b1AR
antagonist), ICI 118,551 (b2AR antagonist), and SR 59230A
(b3AR antagonist). Using this approach, effects on CDI were
detected only when the b2AR agonist salmeterol was used in
combination with CGP 20712 and SR 59230A (reduction of Dinact
from 33.561.2% to 28.461%, n=4; Figure 4A). For the other
two bAR subtypes, no significant modulation of CDI was obtained
in this set of experiments (data not shown). These results clearly
demonstrate that b2AR specifically contribute to CDI modulation
in dLGN TC neurons.
Localization of b2ARs in cultured TC neurons
Next, we analyzed the specific expression and localization of
b2AR in 10 days old cultured thalamic neurons and performed
double immunostaining using an antibody against b2AR
(Figure 4B) in combination with an antibody against the dendritic
marker protein microtubule associated protein 2 (Map2;
Figure 4B). The expression of both proteins was detected with
b2AR mainly localized in somatic and proximal dendrites of TC
neurons (Figure 4B, merge image), cellular compartments that are
involved in modulation of CDI in TC neurons.
Blocking of PKA suppresses bAR-dependent modulation
of CDI in TC neurons
Next, we assessed the possible contribution of PKA in CDI
modulation of TC neurons by intracellular application of a PKA
inhibitor (PKI, 10 mM) in whole cell patch clamp experiments. As
shown in Figure 5A, the degree of inactivation was significantly
reduced from 44.662.3% (n=5) under control conditions to
35.161.1% (n=4, p,0.001; Figure 5A) when TC neurons were
challenged with salmeterol (10 mM), while in combination with
PKI the inhibitory effect of bAR stimulation was absent
(Dinact=43.261%; n=5). These findings indicate that the
modulation of CDI in TC neurons depends on the activity of
PKA.
To address the possible association between PKA and CaV1.2,
we performed double immunostainings of cultured TC neurons
treated with the general bAR agonist isoproterenol. In this set of
experiments we used an antibody directed against the regulatory
subunit IIb of PKA (PKARIIb), which is highly expressed in
thalamus and hippocampus (Figure 5C). Image analysis pointed to
a close spatial proximity of the two proteins at the somato-
dendritic junction following bAR stimulation (Figure 5B). On the
other hand untreated cells showed more somatic expression of the
PKARIIb (data not shown).
AKAPs play a crucial role in the modulation of CDI in TC
neurons
Next, we investigated the possible contribution of AKAP in CDI
modulation in TC neurons. AKAP is assumed to simultaneously
bind to PKA, Ca
2+ channels, and protein phosphatases, including
calcineurin [17]. Therefore a selective AKAP inhibitory peptide
which binds to the PKA binding sites of AKAP thereby blocking
the binding of intracellular PKA and a corresponding control
peptide which allows normal PKA binding were used. When
salmeterol (10 mM) was applied in the presence of intracellular
AKAP inhibitory peptide (10 mM), the degree of inactivation
(37.661.5%, n=9; Figure 6A and 6B) was comparable to control
conditions (39.560.5, n=4, p.0.05) but different from conditions
where salmeterol was applied alone (34.560.3%, n=4, p,0.01;
Figure 6A and 6B). Using the same experimental protocol,
application of salmeterol in the presence of intracellular control
peptide did not change the reduction in CDI (data not shown). In
summary, these experiments point to a role of AKAP in the
modulation of CDI in TC neurons.
Complex formation by the main components of the b-AR
signaling cascade in TC neurons
After stimulation of the b-AR signaling cascade, it is assumed that
a ternary complex is formed between PKA, AKAP, and CaV1.2, the
formationofwhichisimportantforCDI modulation inTCneurons.
In order to find evidence corroborating this assumption, we next
performed immunocytochemical staining using antibodies specific
forCaV1.2(Figure7A,upperleftpanel),AKAP5(Figure7A,middle
leftpanel),andPKARIIb(Figure7A,lowerleftpanel),in10daysold
cultured thalamic neurons. Fluorescence imaging revealed that all
three proteinsare denselyexpressedinsomaticregionsand proximal
dendrites of TC neurons. Merged images pointed to rather close
spatial association of the three proteins (Figure 7A, right panel). In
contrary to CaV1.2, another calcium channel CaV2.1 is similarly
expressed at somatic regions and proximal dendrites but also
additionally in distal dendrites (Figure S2).
Protein-protein interactions between components of the
ternary inactivation complex
Since immunocytochemical stainings pointed to the possibility
that PKA, AKAP, and CaV1.2 are located close to each other,
thereby contributing to the CDI process, we performed pull down
assays which confirmed an interaction between PKARIIb and
AKAP7 (Figure 7B) as well as PKARIIb and PKAcsb (Figure 7D).
Control incubations of samples of interest with the appropriate
fusion-protein partner (empty vector) showed no signal in Western
blots. Moreover, indications for an interaction of PKARIIb with
another member of the AKAP family, namely AKAP5, were
obtained by co-immunoprecipitation experiments. Therefore,
magnetic beads coupled to GFP antibody and Western blotting
using a PKARIIb-specific antibody were used to verify the binding
of PKARIIb to GFP-tagged AKAP5 (Figure 7C). Control
incubations of samples of interest (c-myc PKARIIb) with the
appropriate fusion-protein partner (empty GFP vector) showed no
signal in Western blots. These results provided further evidence for
a close coupling between PKA and AKAP in the thalamus.
Phosphorylation and dephosphorylation processes in
modulation of CDI
It is well documented that phosphorylation/dephosphorylation
processes play an important role in the regulation of calcium
channel activity [3,9]. In an additional series of patch clamp
experiments we focused on the role of dephosphorylation in the
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double-pulse protocol was applied using the phosphatase inhibitor
okadaic acid (OA; 10 mM alone; p.0.05; Figure 8A), or in
combination with isoproterenol (10 mM; Figure 8B). After blocking
dephosphorylation processes, the degree of inactivation is reduced
to 29.361.1% (n=5) in comparison to bAR stimulation alone
(35.762%, n=5; p ,0.01), and non-stimulated control cells
which showed Dinact of 4063.3% (n=5; p ,0.001) in these
experiments.
Next, the expression of protein phosphatases PP2A was
investigated in 10 days old cultured thalamic neurons by using
antibodies for PP2A (Figure 8C, upper right panel) and CaV1.2
Figure 4. b2AR specifically modulates CDI in TC neurons of dLGN. (A) Representative current traces recorded under control conditions (upper
left panel) and during extracellular application of specific b2AR agonist salmeterol (10 mM) plus antagonists for the other two types of receptor (CGP
20712 dihydrochloride-b1 antagonist and SR 59230A hydrochloride-b3-antagonist, 100 mM each; lower left panel) elicited by the indicated pulse
protocol (middle left panel). The bar graph (right panel) represents Dinact under different recording conditions (as indicated). The mean value of four
cells recorded under control conditions was taken for comparison with four cells recorded under 10 mM salmeterol plus 100 mM b1+b3 antagonists.
Data are presented as means 6 SEM of several independent experiments. **P,0.01. Significance of salmeterol plus antagonists versus control was
calculated by Student’s t test. The degree of inactivation is given by the normalized current amplitude of the mean postpulse I/V at +10 mV. (B)
Immunocytochemical analysis of primary cultures of the dorsal thalamus using MAP2 specific antibody (left upper panel, red) and b2AR specific
antibody (left down panel, green). The merged picture revealed the co-expression of these two proteins in somatic regions and proximal dendrites.
Enlarged inlay represents magnification of the area indicated by the rectangle. Yellow dots represent places were these two proteins are in close
proximity. Data shown are representative pictures from several independent immunostainings and preparations of neurons. In all cases, omission of
primary antibodies resulted in no fluorescence signal above background (negative control).
doi:10.1371/journal.pone.0027474.g004
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in somatic regions and proximal dendrites of TC neurons
(Figure 8C, lower panel). Merged pictures pointed to a close
spatial arrangement.
Discussion
The present study provides clear evidence that the CDI of HVA
Ca
2+channels is decreased by bAR signaling in central neurons.
Moreover, we present findings that are in agreement with the
existence of a possible protein complex including PKA, AKAP,
and CaV1.2 which underlies the modulation of CDI. The most
important findings of the present study are: (i) Classical double
pulse protocols reveal the occurrence of CDI in TC neurons in a
slice preparation; (ii) Activation of b2AR induces the down-
regulation of CDI; (iii) Blocking of PKA signaling completely
suppresses the effect of bAR stimulation on CDI, (iv) AKAP might
play a crucial role in CDI modulation and the docking of PKA to
sites close to CaV1.2 (see Text S1). Moreover, blocking of the
interaction between AKAP and PKA significantly reduces CDI
and translocation of PKA. (v) Phosphorylation and dephosphor-
ylation processes represent the basis for bidirectional up- and
down-regulation of CDI in TC neurons, respectively.
bAR stimulation and modulation of CDI of CaV1.2 via
phosphorylation and dephosphorylation processes
We have previously demonstrated the existence of CDI of HVA
Ca
2+ currents in TC neurons in different (acutelyisolated cells,
brain slices) thalamic preparations [5,8,9,10]. Based on these
findings, the basic features of CDI in TC neurons can be defined
as follows: (i) Under control conditions the degree of inactivation
varies between about 35–40%. (ii) In addition to L-type Ca
2+
channels, Q-type channels are also governed by CDI. (iii) CDI
is influenced by a number of cellular mechanisms including
repetitive neuronal activity, phosphorylation and dephosphoryla-
tion, Ca
2+-binding proteins, the cytoskeleton, and intracellular
Ca
2+ release. The present study adds to these findings by
demonstrating the specific influence of b2AR stimulation via
PKA and scaffolding proteins of the AKAP family on the degree of
CDI.
Figure 5. Inhibition of PKA completely suppresses the effect of bAR stimulation on CDI in TC neurons. (A) Representative current traces
recorded under control conditions (upper left panel) and in the presence of the specific b2AR agonist salmeterol alone (10 mM; left middle panel) or in
combination with PKI 14–22 amide (10 mM; lower left panel). The bar graph represents Dinact under different recording conditions (as indicated). The
mean value of five cells recorded under control conditions was taken for comparison with four cells recorded under 10 mM salmeterol and five cells
recorded under 10 mM salmeterol plus PKI 14–22 amide. Data are presented as means 6 SEM of several independent experiments. ***P,0.001.
Significance of salmeterol plus PKI (n=5) versus salmeterol alone (n=4) was calculated by Student’s t test. The degree of inactivation is given by the
normalized current amplitude of the mean postpulse I/V at +10 mV. (B) Close co-expression of the main modulator of CDI, PKA (green) and CaV1.2
(red) in cultured neurons. Yellow dots represent places were these two proteins are in close proximity. Data shown are representative pictures from
several independent immunostainings and preparations of neurons. In all cases, omission of primary antibodies resulted without signal (negative
control). (C) Indicated brain regions were immunostained with antibodies specific for PKARIIb and CaV1.2. Thalamic regions LGN and VB revealed very
strong interaction patterns in merged pictures. Association of these proteins is still present in hippocampus but on lower level. DG (dentate gyrus),
PoDG (polymorph layer of the dentate gyrus).
doi:10.1371/journal.pone.0027474.g005
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which leads to phosphorylation of Ca
2+ channels in a cAMP-
dependent manner via PKA activation, significantly reduced the
degree of inactivation of L-type Ca
2+ channels. The same results
were obtained when channel dephosphorylation was inhibited.
This indicates that phosphorylation keeps L-type Ca
2+ channels
in a state of high open probability, ready to open during
depolarization [9,25]. The modulation of L-type Ca
2+ channels
through phosphorylation via different second messenger systems is
well established, and includes phosphorylation by PKA and CaM
kinase II (for review, see [26,27]). Both types of modulation result
in an increase in peak current amplitude [28,29]. Furthermore,
CDI has been shown to be reduced by activation of cAMP-
dependent phosphorylation [9,25,30]. Therefore, both the incre-
ment in HVA Ca
2+ current amplitude and the reduction of CDI
after bAR stimulation observed in the present study are consistent
with a phosphorylation of L-type Ca
2+ channels by PKA.
The serine residue at position 1928 (Ser1928) of CaV1.2
channels is one important target of PKA activity in heart and
brain [31,32,33]. However, it has been recently shown that
mutation of Ser1928 of cardiac L-type Ca
2+ channels has only a
small effect on channel phosphorylation after bAR stimulation
[34], pointing to the existence of additional phosphorylation sites
[34,35,36]. Moreover, meaningful regulation of channel activity
by PKA phosphorylation requires a proper balance with depho-
sphorylation processes. Several studies in hippocampal neurons
have shown that protein phosphatases including PP1, PP2A, and
calcineurin directly bind to the C-terminal region of CaV1.2
[17,31,33]. Moreover, the signaling pathway from b2AR to the
CaV1.2 channel, including G-proteins, adenylate cyclase, PKA
and the counterbalancing protein phosphatases, forms a closely
associated protein complex in the forebrain [13]. However, the
role of this complex in context of CDI modulation has not been
addressed yet. CaV1.2 channels are expressed in TC neurons [8]
and the existence of bARs, coupled positively to adenylate cyclase
in these neurons, has been shown [37]. Moreover, we previously
demonstrated effects of calyculin A and ascomycin, which are
blockers of PP1, PP2A, and calcineurin [38] on CDI and Ca
2+
current amplitude in TC neurons [9]. The present study on brain
slices confirmed and extended previous findings obtained in
acutely isolated TC neurons by identifying b2AR as the receptor
subtype involved in CDI modulation and showing that blocking
protein phosphatases by okadaic acid, has a significant effect on
CDI during b-AR stimulation. From our data, it is therefore
reasonable to conclude that PKA and protein phosphatases
antagonistically modulate CDI of CaV1.2 channels in TC neurons
via phosphorylation and dephosphorylation processes.
Although our experiments with okadaic acid demonstrated the
role of dephosphorylation processes in modulation of CDI after
bAR stimulation in TC neurons, the specific type of phosphatase
involved in TC neurons is still not clear. The original model of
CDI in Helix aspersa included a dephosphorylation cycle by
calcineurin as the fundamental step leading to channel closure
[39]. Later, evidence for and against an involvement of calcineurin
was found [17,40,41,42,43,44,45]. In TC neurons, application of
the calcineurin blocker ascomycin boosts CDI [9,46]. Although
these observations clearly indicate a modulation of CDI by
calcineurin in TC neurons, the inactivation process itself is
probably not a dephosphorylation reaction. As shown above, PKA
is the main enzyme which phosphorylates CaV1.2 channels,
thereby keeping them in an open state (increasing their open
probability) and restraining the effects of CDI. Besides this
phosphorylation processes that occur after bAR stimulation, there
might be a constant dephosphorylation driven by PP1 and PP2.
AKAP mediates the modulation of CaV1.2 channel during
bAR stimulation
CaV1.2 channels can physically associate with either AKAP5 or
AKAP7 through a leucine zipper interaction [17,47]. Both, the
modulation of channels and its downstream signaling depend upon
the identity of the associated AKAPs. Although both AKAP
Figure 6. Inhibition of PKA binding to AKAPs suppresses the effect of bAR stimulation in TC neurons. (A) Representative current traces
recorded under control conditions (upper left panel) and in the presence of the specific b2AR agonist salmeterol alone (10 mM; left middle panel) or in
combination with InCELLect
TM AKAP St-Ht31 inhibitory peptide (10 mM; lower left panel). (B) The bar graph represents Dinact under different
recording conditions (as indicated). The mean value of four cells recorded under control conditions was taken for comparison with four cells recorded
under 10 mM salmeterol and nine cells recorded under 10 mM salmeterol plus InCELLect
TM AKAP St-Ht31 inhibitory peptide. Data are presented as
means 6 SEM of several independent experiments. **P,0.01. Significance of salmeterol (n=4) versus salmeterol plus InCELLect
TM AKAP St-Ht31
inhibitory peptide (n=9) was calculated by Student’s t test. The degree of inactivation is given by the normalized current amplitude of the mean
postpulse I/V at +10 mV.
doi:10.1371/journal.pone.0027474.g006
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cineurin and thereby confers unique characteristics upon AKAP5-
complexed L-type channels in neurons [17]. AKAP5 is the major
AKAP protein in neurons, where it is widely distributed and has
been shown to anchor protein kinases and other signaling proteins
to multiple receptors and ion channels [48]. On the one side,
AKAP5 recruits PKA and calcineurin to the AMPA receptor [49],
associates with CaV1.2 [14,50] in neurons, recruits PKA and
calcineurin to the channel and is necessary for the bAR sti-
mulation of L-type calcium currents [13,14,48] as well as for the L-
type calcium current-mediated activation of the transcriptional
regulator NFATc4 [17]. On the otherside, AKAP5 binds also to
b2AR and facilitates receptor phosphorylation and signaling [51].
Moreover, colocalization with CaV1.2 and postsynaptic density
(PSD) proteins in dendritic spines of hippocampal neurons has
been shown [52]. Three different binding sites for AKAP5 were
described in the N terminus, the cytoplasmic loop connecting
repeats I and II, and in the C terminus of CaV1.2 [14]. The C-
terminal leucine zipper was shown to be essential for AKAP
binding and for bAR stimulation and reversible phosphorylation
of CaV1.2 in heart muscle and in neurons [17,47]. Mutation of the
three basic residues of this motif blocked AKAP5 and PKA
binding and phosphorylation of the Ca
2+ channel in response to
bAR stimulation [17]. Moreover, mutation of known binding sites
Figure 8. The role of dephosphorylation processes in CDI modulation of TC neurons. (A) Representative current traces recorded under
control conditions (upper left panel) and in the presence of okadaic acid (OA) (10 mM; left down panel). The bar graph (right panel) represents Dinact
under different recording conditions (as indicated). The mean value of three cells recorded under control conditions was taken for comparison with
three cells recorded under 10 mM OA. (B) Representative current traces recorded under control conditions (upper left panel) and in the presence of
the isoproterenol alone (10 mM; left middle panel) or in combination with OA (10 mM; lower left panel). The bar graph (right panel) represents Dinact
under different recording conditions (as indicated). The mean value of five cells recorded under control conditions was taken for comparison with five
cells recorded under 10 mM isoproterenol and five cells recorded under isoproterenol plus OA. Data are presented as means 6 SEM of several
independent experiments. ***P,0.001. Significance of isoproterenol plus OA (n=5) versus controls (n=5) was calculated by Student’s t test.
**P,0.01. Significance of isoproterenol (n=5) versus isoproterenol plus OA (n=5) was calculated by Student’s t test. The degree of inactivation is
given by the normalized current amplitude of the mean postpulse I/V at +10 mV. (C) Immunocytochemical analysis of primary cultures of the dorsal
thalamus using CaV1.2- (left panel, green) and PP2A-specific antibodies (right panel, red). Merge picture showed close association of the two proteins,
especially in somatic regions and proximal dendrites. Data shown are representative pictures from several independent immunostainings and
thalamic neurons preparations. In all cases, omission of primary antibodies resulted in no fluorescence signal above background (negative control).
doi:10.1371/journal.pone.0027474.g008
Figure 7. Interaction partners important for CDI modulation in TC neurons. (A) Immunocytochemical analysis of primary cultures of the
dorsal thalamus using CaV1.2- (red), AKAP150- (green) and PKARIIb- (blue) specific antibodies. Merged picture shows the close connection of the
components of the proposed ternary complex, especially in somatic regions and proximal dendrites. Enlarged inlay represents a magnification of the
area indicated by the rectangle. Data shown are representative pictures from several independent immunostainings and preparations of neurons. In
all cases, omission of primary antibodies resulted without signal (negative control). Western blot analysis and pull down assays were done as
described in "Methods". (B) Interaction of AKAP7-MBP and PKARIIb-c-myc was detected using antibodies against c-myc. (C) IP of PKARIIb-c-myc and
AKAP5-GFP detected after incubation with GFP-coupled magnetic beads using antibodies derived against PKARIIb.( D) Existence of PKA holoenzyme
consisting of PKARIIb-GST and PKAcsb-GFP was detected with antibodies against GFP protein.
doi:10.1371/journal.pone.0027474.g007
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did not change membrane expression of CaV1.2 [52]. The above
findings indicate that binding of these proteins is necessary for the
regulation of CaV1.2 after bAR stimulation but does not have an
influence on the membrane localization of CaV1.2.
Based on the previous findings discussed above and the results
presented here, we propose the following role for AKAP in the
regulation of CDI in TC neurons. Following bAR stimulation, AC
gets activated via G-proteins and produces cAMP which then
activates PKA. With support of AKAPs, PKA targets its final
effector, the CaV1.2 channels and phosphorylates them (see Figure
S1). In the present study we demonstrated that blocking the
binding of AKAP to PKA significantly reduces CDI. Moreover,
under similar conditions we have shown that PKA phosphoryla-
tion of CaV1.2 and translocation of this enzyme close to the
channel depends on binding of PKA and AKAPs in hippocampal
neurons (see Text S1 & Figure S3). Most recent studies de-
monstrated that AKAP5 is required to localize both RIIa and RIIb
containing holoenzymes to the dendritic regions of neurons in
the hippocampus and striatum. PKA is dramatically delocalized
within dendrites in both the KO and D36 (mutant that lacks the
PKA binding domain of AKAP5) mice indicating that no other
AKAP subtype is able to compensate and maintain normal PKA
localization [53]. Our study confirmed an interaction between
AKAP and PKA in pull down assays and demonstrated that after
stimulation of the bAR signaling cascade a ternary complex is
formed between PKA, AKAP, and CaV1.2 and that the formation
of this complex is important for CDI modulation in TC neurons.
Moreover, as mentioned before, AKAP5 also targets calcineurin
which is able to activate protein phosphatase PP1 [54] and
therefore might have multiple function in regulation of CDI by
influencing both phosphorylation by PKA and dephosphorylation
processes.
Functional significance of Ca
2+ channel phosphorylation
after b-AR stimulation
Release of transmitters from a number of brainstem terminals
modulates the behavioural states of an individual by depolarizing
TC relay neurons [37]. During states of slow-wave sleep, thalamic
relay neurons are hyperpolarized and display rhythmic burst
activity [11]. During states of wakefulness, these cells are de-
polarized and display tonic single spike activity, resulting in the
faithful transmission of sensory signals through the dorsal
thalamus. The shift from burst activity to tonic activity is mediated
by increased activity of ascending brainstem fibres that are thought
to increasingly release acetylcholine (ACh), noradrenaline (NA)
and serotonin (5-HT) during wakefulness. Both NA via b-receptors
and 5-HT via an unknown 5-HT receptor subtype, activate
adenylate cyclase [37] in TC relay neurons and are thus able to
positively modulate HVA Ca
2+ currents.
When attempting to integrate the findings of the present study
into the known framework of thalamic physiology it can be
assumed that HVA Ca
2+ currents are especially activated during
tonic firing. Furthermore, following release of NA, HVA Ca
2+
current amplitudes will be increased while CDI is decreased.
Another consequence of bAR stimulation may be the AC/cAMP-
dependent inhibition of high conductance Ca
2+-dependent K
+
(BKCa) channels in sensory TC neurons [55]. In addition, tonic
sequences of action potentials are coupled to CICR from
intracellular stores, thereby further increasing Ca
2+ entry into
TC neurons during wakefulness [6]. It has been shown that
intracellular Ca
2+ release provides Ca
2+ that contributes to CDI
and activates BKCa channels in TC neurons [5,6]. Computer
modelling indicated that activation of BKCa channels leads to the
occurrence of spike frequency adaptation (P. Meuth & T. Budde,
unpublished observations), a condition that would impair the
faithful 1:1 relay of incoming trains of sensory action potentials.
These data indicate a fine-tuned interplay between activity
dependent Ca
2+ influx, phosphorylation/dephosphorylation pro-
cesses and the mode of activity, possibly to enable faithful signal
integration and transfer during wakefulness.
Future studies will have to unravel the different modulatory
pathwaysthatactupstreamofthemultipleCDImechanismsthereby
pointing to additional functions of CDI and unraveling further the
elusive role of HVA Ca
2+ channels in thalamic physiology.
Supporting Information
Text S1 AKAPs assist in PKA translocation from
somatic regions to the plasma membrane. Translocation
of PKARIIb after bAR stimulation with isoproterenol in
hippocampal neurons.
(DOC)
Figure S1 Main components of the bAR signaling
cascade in dLGN.
(TIF)
Figure S2 Differential expression of CaV2.1 from
CaV1.2 in TC neurons of thalamus. Immunocytochemical
analysis of primary cultures of the dorsal thalamus using CaV2.1-
(green) and MAP2-specific (neuronal marker, red) antibodies. Merge
image showed expression of these two proteins in somatic, proximal
and in distal regions of TC neurons. Data shown are representative
pictures from several independent experiments. In all cases, omission of
primaryantibodies resulted in staining without signal (negative control).
(TIF)
Figure S3 PKA translocation from somatic regions to
the plasma membrane. (A) Cultured hippocampal cells were
treated with 50 mM isoproterenol or kept under control conditions
(control/no treatment), fixed and immunostained with PKARIIb
antibody. Enlarged inlays represent magnification of the area
indicated by the rectangle. Note translocation of PKA from
somatic perinuclear region in control cells to more distal regions
close to the plasma membrane and probably Ca
2+ channels in cells
treated with isoproterenol. (B) Ten days old hippocampal cultures
were treated for 5 minutes with 50 mM isoproterenol in
combination with 50 mM control peptide AKAP St-Ht31 (left
panel), 50 mM isoproterenol in combination with 50 mM AKAP
St-Ht31 inhibitory peptide (right panel) and 50 mM isoproterenol
in combination with 7.5 mM Anisomycine (down panel). The cells
were then fixed and immunostained with PKARIIb antibody.
Note that PKA is still translocated to proximal dendrites, after
blocking the association of PKA with AKAPs, translocation is
almost completely inhibited and anisomycine treatment did not
block PKA translocation. (C) Quantification of translocation
experiments using MetaMorph was done by measurement of PKA
distance from centre of the soma to dendrites in pixels after
different treatments. Data are presented as means 6 SEM of
several independent experiments. ***P,0.001, Anova test.
(TIF)
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